The Renovo business model is focused on partnerships
and development agreements. However, this may not be
the right arrangement for some companies.
Renovo performs fee-for-service contract research for
pharmaceutical companies exclusively though our
partner company Triclinic Labs. For companies
interested in Renovo's cocrystal technology, but would
prefer to own all resulting cocrystal intellectual property
outright rather than forming a partnership or joint venture
with Renovo, please direct all enquiries to Triclinic Labs.
If you have questions about what kind of working
relationship with Renovo would be appropriate for your
company, please contact us to discuss your project.
2011 Renovo Research, LLC. All rights reserved.
Cocrystals and the pet
food recall of 2007
In 2007 it was discovered that chinese pet
food suppliers added melamine and/or
cyanuric acid to pet food supplies in an
attempt to increase the perceived protein
content. Large amounts of pet food were
recalled when it was discovered that pets
were exhibiting high rates of kidney failure
after eating the contaminated pet food. The
renal failure was caused by a low solubility
cocrystal of melamine and cyanuric acid
that formed in the kidneys.
The hydrogen bonding pattern in the 1:1
melamine:cyanuric acid cocrystal is shown
cocrystals of pharmaceuticals...